Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 04, 2015 5:01 PM ET


Company Overview of DaVita Clinical Research

Company Overview

DaVita Clinical Research, a clinical research facility, provides kidney care research services for pharmaceutical and biotech companies. It offers early clinical research services, which include Phase I-IIb renal studies, bioequivalence studies, pharmacokinetics/pharmacodynamics, and drug delivery and administration; and clinical development services, such as clinical trial management, study design and protocol development, biostatistics, medical and scientific writing, regulatory affairs, quality assurance, and preapprovals. The company also operates a clinical network of physicians, medical groups, and dialysis centers in the United States; and develops a clinical informatics system, which...

825 South 8th Street

Suite 300

Minneapolis, MN 55404

United States

Founded in 1994





Key Executives for DaVita Clinical Research

Senior Director of Business Development
Early Clinical Scientific Officer
Age: 59
Vice President and General Manager
Vice President of Research & Publishing and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2015.

DaVita Clinical Research Key Developments

Aethlon Medical, Inc. Announces Agreement with DaVita Clinical Research

Aethlon Medical Inc. announced that it has entered into a definitive agreement with DaVita Clinical Research (DCR) to provide clinical management services to support the forthcoming feasibility study of the Aethlon Hemopurifier. The clinical trial site location will be DaVita MedCenter Dialysis in Houston.

Aethlon Medical(R) Announces Agreement with DaVita Clinical Research

Aethlon Medical Inc. announced that it has reached an agreement in principle with DaVita Clinical Research to provide clinical management services that will support forthcoming studies of the Aethlon Hemopurifier(R). The Hemopurifier(R) is a first-in-class therapeutic device that targets the rapid elimination of circulating viruses and tumor-secreted exosomes that suppress the immune system of cancer patients.

Raptor Pharmaceuticals and DaVita Clinical Collaborate on Nephropathic Cystinosis Program

Raptor Pharmaceuticals Corp. and DaVita Clinical Research have announced a collaboration to screen blood samples from patients with end-stage renal disease, or ESRD, in an effort to identify patients with unrecognized late-onset nephropathic cystinosis. DCR will supply blood samples with clinical data annotation from DCR's biorepository of over 4,000 patients with ESRD. The screening effort will employ high-throughput genetic sequencing of the cystinosin, lysosomal cystine transporter (CTNS) gene, mutations of which result in cystinosis. Results of the collaboration may reveal new insights into the prevalence of missed late-onset cystinosis in this at-risk patient population.

Similar Private Companies By Industry

Company Name Region
APS Summit Care Pharmacy, LLC United States
Premier Micronutrient Corporation United States
Wincott & Associates, LLC United States
Nutra Med, Inc. United States
Agensys, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DaVita Clinical Research, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at